State Street SPDR S&P Pharmaceuticals ETF (NY:XPH)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
16.4% below 52-week high
62.15
51.0952W Low
74.3452W High
1 Week
7.4% below 1-week high
61.961W Low
67.141W High
State Street SPDR S&P Pharmaceuticals ETF (XPH) traded between $51.09 and $74.34 over the past 52 weeks and last traded at $62.15, 16.4% below its 52-week high. Over the past week it ranged between $61.96 and $67.14.
Past 12 Months
-4.9%
-2.8%
-14.6%
+7.5%
+12.6%
+21.5%
1W
-$3.21
1M
-$1.81
3M
-$10.65
6M
+$4.36
YTD
+$6.94
1Y
+$10.99
XPH was +21.5% over the past year, +7.5% over six months, +12.6% year to date, -4.9% in the last week.
12 Months vs Market
XPH
DIA
SPY
QQQ
IWM
Over the past 12 months XPH returned +21.5% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.
Volume & Liquidity
0.60× 3-mo avg
Today 120,184
3-mo avg 201.7K
1W
1M
3M
6M
YTD
1Y
XPH most recently traded 120,184 shares against a 3-month average daily volume of 201.7K. More NewsRead More
Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT? ↗
November 11, 2026
Via The Motley Fool
Topics
ETFs
Why Did AQST Stock Plunge 40% In Pre-Market Today? ↗
January 09, 2026
Via Stocktwits
Better Pharma ETF: iShares IHE vs. State Street XPH ↗
October 10, 2026
Via The Motley Fool
Topics
ETFs
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma ↗
October 10, 2026
Via The Motley Fool
Topics
ETFs
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals ↗
October 04, 2026
Via The Motley Fool
Topics
ETFs
IXJ vs XPH: Global Healthcare ETF or Pharma Focus? ↗
September 11, 2026
Via The Motley Fool
Topics
ETFs
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH ↗
September 10, 2026
Via The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? ↗
September 10, 2026
Via The Motley Fool
Topics
ETFs
XPH vs PJP: Which Pharma ETF Offers Better Value ↗
August 17, 2026
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
March 04, 2026
Via Stocktwits
Via Stocktwits
Why Did CRMD Stock Crash 28% Today? ↗
January 08, 2026
Via Stocktwits
Frequently Asked QuestionsIs State Street SPDR S&P Pharmaceuticals ETF publicly traded?
Yes, State Street SPDR S&P Pharmaceuticals ETF is publicly traded.
What exchange does State Street SPDR S&P Pharmaceuticals ETF trade on?
State Street SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Pharmaceuticals ETF?
The ticker symbol for State Street SPDR S&P Pharmaceuticals ETF is XPH on the New York Stock Exchange
What is the current price of State Street SPDR S&P Pharmaceuticals ETF?
The current price of State Street SPDR S&P Pharmaceuticals ETF is 62.15
When was State Street SPDR S&P Pharmaceuticals ETF last traded?
The last trade of State Street SPDR S&P Pharmaceuticals ETF was at 11/20/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Pharmaceuticals ETF?
The market capitalization of State Street SPDR S&P Pharmaceuticals ETF is 2.24M
How many shares of State Street SPDR S&P Pharmaceuticals ETF are outstanding?
State Street SPDR S&P Pharmaceuticals ETF has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>